Effectiveness of Technetium-99 m monoclonal antibody scintigraphy for the detection of infectious focus in a case series in cirrhotic patients [0.03%]
一项病例系列研究：99mTc单克隆抗体闪烁扫描检测肝硬化患者感染灶的效果
Hale Gokcan,Ayse Aktas,Omer Ozturk et al.
Hale Gokcan et al.
Determination of the upper limits of normal serum alanine aminotransferase (ALT) level in healthy Turkish population [0.03%]
在健康土耳其人群中确定正常血清丙氨酸氨基转移酶(ALT)水平上限的测定
Bulent Degertekin,Nurdan Tozun,Figen Demir et al.
Bulent Degertekin et al.
Background and aim: Recent studies have reported that the widely accepted range of upper limits of normal (ULN) alanine aminotransferase (ALT) levels (ULN
Anti-SLA and AMA-positive celiac disease: A report of two cases and evaluation of autoimmune liver serology [0.03%]
抗SLA和AMA阳性型乳糜泻的病例报告及其自身免疫性肝病血清学检查结果评估
Nurhan Demir,Cumali Efe,Seyhmus Olmez et al.
Nurhan Demir et al.
Background and Aim: Antibodies to soluble liver antigen (anti-SLA) and anti-mitochondrial autoantibodies (AMA) are two specific serological markers of autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC). They are rarely detecte...
Case Reports
Hepatology forum. 2020 May 21;1(2):68-71. DOI:10.14744/hf.2020.2020.0005 2020
Immunoglobulin light chain amyloidosis presenting as Budd-Chiari syndrome [0.03%]
免疫球蛋白轻链淀粉样变性呈巴德-基亚里综合征发病形式
Mubin Ozercan,Irem Eser,Saba Kiremitci et al.
Mubin Ozercan et al.
Abdullah Tarik Aslan,Hatice Yasemin Balaban
Abdullah Tarik Aslan
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19), is highly contagious and has a variety of clinical manifestations, including liver injury. There have been a few re...
The effect of transarterial chemoembolization therapy on survival in patients with non-resectable hepatocellular carcinoma: Single-center study results [0.03%]
肝动脉化疗栓塞治疗不可手术切除的原发性肝癌患者生存效果的单中心研究结果分析
Mehmet Kolu,Osman Dere,Suleyman Sonmez
Mehmet Kolu
Background and aim: This study was designed to investigate the tumor response and effect of drug-eluting transarterial chemoembolization (DEB-TACE) treatment on survival in patients diagnosed with hepatocellular carcinoma...
A novel insight into the pathophysiology of autoimmune hepatitis: An immune activator mutation in the FLT3 receptor [0.03%]
自身免疫性肝炎病理生理的新见解：FLT3受体上的免疫激活突变
Muhammed Yuksel,Ayse Armutlu,Farinaz Nazmi et al.
Muhammed Yuksel et al.
Autoimmune hepatitis (AIH) is a chronic progressive autoimmune liver disease characterized by hypergammaglobulinemia, interface hepatitis, a female preponderance, and the presence of autoantibodies in most patients. The presence of HLA-DR3/...
The relationship between polyphenols and miRNAs: A novel therapeutic strategy for metabolic associated fatty liver disease [0.03%]
多酚与miRNA的关系：一种治疗代谢相关脂肪性肝病的新策略
Hatice Merve Bayram,Fatih Eren,Fatma Esra Gunes
Hatice Merve Bayram
Metabolic-associated fatty liver disease (MAFLD) is a public health problem that is increasingly recognized, currently affecting up to a quarter of the world's adult population. Although a biopsy is the current gold standard to diagnose MAF...
New therapeutic players on the horizon: Edible plant derived exosomes [0.03%]
前景中新疗法的参与者：可食用植物来源的外泌体
Murat Kantarcioglu
Murat Kantarcioglu
Are nucleos(t)ide analogues effective against severe outcomes in COVID-19 and hepatitis B virus coinfection? [0.03%]
核苷类似物对新冠肺炎和乙型肝炎病毒重叠感染严重结局有效吗？
Gupse Adali,Pinar Gokcen,Fatih Guzelbulut et al.
Gupse Adali et al.
Background and aim: The impact of chronic hepatitis B virus (HBV) infection and nucleos(t)ide analogue (NUC) treatment on disease severity and clinical outcomes in patients with coronavirus 2019 (COVID-19) is unknown. The...